Adjuvant therapy for stage I and II non-small cell lung cancer

被引：1
|
作者：
Dorr, VJ
Perry, MC
机构：
[1] Div. of Hematology/Medical Oncology, Ellis Fischel Cancer Center, University of Missouri, Columbia, MO 65203
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1997年 / 11卷 / 02期
关键词：
D O I：
10.1016/S0889-8588(05)70430-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Even after curative resection, the overall 5-year survival rate for stage I and II non-small cell lung cancer remains less than optimal. In an attempt to improve survival, adjuvant therapy after curative resection has been evaluated. Chemotherapy, immunotherapy, radiotherapy, and various combinations of these have been investigated as means to improve survival. This article reviews these studies. At this time, adjuvant therapy remains investigational and its use should be limited to clinical trials.
引用
收藏
页码：267 / +
页数：1
相关论文
共 50 条
  • [1] Adjuvant Therapy for Stage I and II Non-Small Cell Lung Cancer
    Naylor, Evan C.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 585 - +
  • [2] Therapy for stage I and stage II non-small cell lung cancer
    Tanoue, LT
    Ponn, RB
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 173 - +
  • [3] Operation and adjuvant therapy of non-small cell lung cancer (Stage I to operable IIIA)
    Eberhardt, Wilfried
    Fietkau, Rainer
    Griesinger, Frank
    Passlick, Bernward
    Stuschke, Martin
    ONKOLOGIE, 2006, 29 : 7 - 10
  • [4] Radiation therapy of stage I and II non-small cell lung cancer (NSCLC)
    Zierhut, D
    Bettscheider, C
    Schubert, K
    van Kampen, M
    Wannenmacher, M
    LUNG CANCER, 2001, 34 : S39 - S43
  • [5] Hypofractionated Radiation Therapy for Stage I and II Non-small Cell Lung Cancer
    Kuremsky, J. G.
    Petty, W. J.
    Miller, A.
    Hinson, W. H.
    Hampton, C. J.
    Blackstock, A. W.
    Urbanic, J. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S153 - S154
  • [6] Radiation Therapy for Early Stage (I/II) Non-Small Cell Lung Cancer
    Jeremic, Branislav
    Casas, Francesc
    Wang, Luhua
    Perin, Branislav
    CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 87 - 93
  • [7] The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer
    Horn, Leora
    Sandler, Alan B.
    Putnam, Joe B., Jr.
    Johnson, David H.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (05) : 377 - 383
  • [8] Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer
    Serke, Monika
    CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 135 - 144
  • [9] Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancer
    Pisters, KMW
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 23 - 28
  • [10] Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer
    Watanabe, Shun-ichi
    Nakagawa, Kazuo
    Suzuki, Kenji
    Takamochi, Kazuya
    Ito, Hiroyuki
    Okami, Jiro
    Aokage, Keiju
    Saji, Hisashi
    Yoshioka, Hiroshige
    Zenke, Yoshitaka
    Aoki, Tadashi
    Tsutani, Yasuhiro
    Okada, Morihito
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (12) : 1112 - 1118
12345